Prefilled Syringes Market Size, Share, Revenue, Forecast 2023-2028

How big is the Prefilled Syringes Market?

IMARC Group, a leading market research company, has recently releases report titled “Prefilled Syringes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The global prefilled syringes market size reached US$ 7.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2023-2028.

What is Prefilled Syringes?

Prefilled syringes are ready-to-use medical devices with a specific dosage of medication or vaccine. They consist of a syringe barrel made of glass or plastic, a plunger, and a needle. They are designed to simplify the administration of drugs or vaccines, which ensures accurate dosing and reduces the risk of errors during the preparation and injection process. They help minimize medication wastage since each syringe contains a precise dosage. They eliminate the need for healthcare professionals or patients to draw up the correct dosage manually, saving time and reducing the risk of dosing errors.

Request for a free sample copy of this report: https://www.imarcgroup.com/prefilled-syringes-market/requestsample

What are the growth prospects and trends in the Prefilled Syringes industry?

The increasing need for biological drugs and vaccines, which require precise dosing and sterile delivery, represents one of the primary factors driving the demand for prefilled syringes around the world. In addition, the surging prevalence of chronic diseases that require frequent injections, such as diabetes and multiple sclerosis, and the rising aging population who are more prone to develop these medical conditions is favoring the growth of the market. Apart from this, the growing use of prefilled syringes as an important component of autoinjectors, which are designed for quick and simple administration of medications and appeal to patients with mobility issues, is influencing the market positively.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Design:

  • Single-chamber Prefilled Syringes
  • Dual-chamber Prefilled Syringes
  • Customized Prefilled Syringes

Breakup by Material:

  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes

Breakup by Closing System:

  • Staked Needle System
  • Luer Cone System
  • Luer Lock Form System

Breakup by Application:

  • Diabetes
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Oncology
  • Others

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bayer AG
  • Becton Dickinson and Company
  • Cardinal Health Inc.
  • Catalent Inc.
  • Fresenius SE & Co. KGaA
  • Gerresheimer AG
  • Nipro Corporation
  • Schott AG
  • Terumo Corporation
  • West Pharmaceutical Services Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/